Recent Press Releases

Silk Therapeutics Raises $6 Million In Series A2 Financing

MEDFORD, Mass., Feb. 3, 2016 /PRNewswire/ -- Silk Therapeutics, Inc., today announced the closing of a $6 million Series A2 financing round. Silk Therapeutics has now raised a total of $10.25 million...

Erin O'Shea Named New HHMI President

Highlights Erin O'Shea is a leader in the fields of gene regulation, signal transduction, and systems biology. She was named HHMI's vice president and chief scientific officer in 2013. ...

Gilead Announces Promotion of Katie Watson to Executive Vice President, Human Resources

FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 1, 2016-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced the promotion of Katie Watson to Executive Vice President, Human Resources. Ms. Watson joined...

U.S. FDA Acknowledges Receipt of Resubmission of Shire's New Drug Application for Lifitegrast for Dry Eye Disease in Adults

LEXINGTON, Massachusetts, February 4, 2016 /PRNewswire/ -- - New FDA action date of July 22, 2016 - Lifitegrast has the potential to be the only product approved in the U.S. in the past decade...

Osiris Therapeutics Announces Leadership Transition

February 03, 2016 04:30 PM Eastern Standard Time COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company focused on developing...

Lion Biotech Names Steven A. Fischkoff Chief Medical Officer

NEW YORK, NY--(Marketwired - February 04, 2016) - Lion Biotechnologies, Inc. (LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...

Corrine Perritano Appointed President Of Beltone North America

CHICAGO--(BUSINESS WIRE)--Beltone, a leader in hearing aids for over 75 years, announced today that Corrine Perritano has been named president of Beltone North America. Drawing on more than 20 years...

Oasmia Makes Key Hires; Strengthens Organizational Structure Entering Commercial Phase

Uppsala, Sweden, February 2, 2016 --- Oasmia Pharmaceutical AB (NASDAQ: OASM), a developer of a new generation of drugs within human and veterinary oncology, today announced that the Company has...

Emmaus Life Sciences Announces Management Promotions

TORRANCE, Calif., Feb. 3, 2016 /PRNewswire/ -- Emmaus Life Sciences, Inc. (the Company or Emmaus), a biopharmaceutical company engaged in the discovery, development and commercialization of...

Human Longevity Hires Key Oncology Leader, Kenneth J. Bloom, M.D., To Head Oncology And Immunotherapy Program

SAN DIEGO, Feb. 3, 2016 /PRNewswire/ -- Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today the appointment of several key people for its oncology genomics...

Achillion (ACHN) Announces Appointments Of Martha Manning As General Counsel And Amy Jennings As Head Of Regulatory Affairs

NEW HAVEN, Conn., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced the addition of two members to the senior management team. Martha Manning, Esq.,...

Voyager Therapeutics (VYGR) Promotes Jeff Goater To Chief Financial Officer

Cambridge, Mass., February 2, 2016 (GLOBE NEWSWIRE) – Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of...

Crescendo Biologics Appoints Dr Barbara Fleck as Head of Intellectual Property

Cambridge, UK - 2 February 2016 – Crescendo Biologics Limited (Crescendo), the drug discovery and developer of Humabody™ VH therapeutics, today announced the appointment of Dr Barbara...

C4 Therapeutics Appoints Andrew Phillips, Ph.D. as Chief Scientific Officer

CAMBRIDGE, Mass. – February 2, 2016 – C4 Therapeutics today announced the appointment of Andrew Phillips, Ph.D. as Chief Scientific Officer. Dr. Phillips joins from the Broad Institute of...

Certara Expands Its Quantitative Systems Pharmacology Group; Appoints Professor Andrzej Kierzek as Head of Systems Modeling

PRINCETON, NJ – Feb. 3, 2016 – Certara®, the global biosimulation technology-enabled drug development company, today announced that it has appointed Andrzej Kierzek, PhD, as head of...

BioStem Technologies (OTC: BSEM) Announces The Appointment Of Dr. Dave Woynarowski As Chief Medical Officer

OAKLAND PARK, FL--(Marketwired - Feb 1, 2016) - Dr. Dave Woynarowski was appointed Chief Medical Officer of Biostem Technologies, Inc. (OTC PINK: BSEM) effective immediately. Dr. Woynarowski received...

BioPharmX Appoints Marie-Louise Bots As Senior VP Of Corporate Development

MENLO PARK, Calif., Feb. 1, 2016 /PRNewswire/ -- Veteran corporate dealmaker Marie-Louise Bots has joined BioPharmX Corporation (NYSE MKT: BPMX) as senior vice president of corporate development...

Merial Appoints Susan Sholtis As President, North America

DULUTH, Ga., Feb. 1, 2016 /PRNewswire/ -- Merial, the animal health division of Sanofi, today announced the appointment of Susan Sholtis as President of its North American operations. Sholtis...

Aoxing Pharma (AXN) Appoints Dr. James Chen As Chief Financial Officer

FOSTER CITY, Calif., Feb. 1, 2016 /PRNewswire/ -- Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research,...

C4 Therapeutics Appoints Andrew Phillips, Ph.D. as Chief Scientific Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--C4 Therapeutics today announced the appointment of Andrew Phillips, Ph.D. as Chief Scientific Officer. Dr. Phillips joins from the Broad Institute of MIT and...
'